Biopharma needs a reset — is 2026 the year?

JANUARY 12 - 13, 2026 | 7:00 AM - 5:00 PM PST
MARRIOTT MARQUIS, SAN FRANCISCO

The biopharma dealmaking playbook for 2026 starts here.

Join Endpoints News at our exclusive event during the JPM Conference, where industry leaders will gather to decode the year's most critical partnerships, funding strategies and investment opportunities. Where does biopharma go from here?

Our curated panel discussions will deliver real talk at a pivotal time in the industry, while the Endpoints Hub offers a premium coworking lounge. This is your retreat from the intensity of Union Square — conduct meetings, connect with peers or simply recharge between sessions.

Early Bird special rates:

Get your in-person ticket now and save 22% off single passes ($200 off)
NEW: Buy 3 passes and save 34% with Early Bird rates ($900 off)

RESERVE YOUR SPOT

Going to be in SF? Save on all-access passes now with Early Bird.
Virtual passes available at no charge

ON THE AGENDA

Fireside chat with Eric Tokat, Co-President of Centerview Partners
Featured conversation with Tony Wood, chief scientific officer at GSK

More details to come — stay tuned.

Eric Tokat
Co-President, Centerview Partners

This isn't just any JPM side event. It's where the best of biopharma learns what everyone else will figure out later.

Whether you’re attending in person with full access to both our sessions and Hub, or joining our livestream from anywhere in the world, you’ll get the insight and connections that will shape your agenda in the new year. Join us.